Weight loss injections such as semaglutide and liraglutide have become increasingly popular for managing obesity in the UK
However, as human erythrocytes are nucleus- and organelle-free cells, the effects of erythrocytic ceramides should be restricted to the plasma membrane and plasma membrane-associated proteins
therefore, longer half-life synthetic analogs have been developed for clinical use, as a new class of antidiabetic agents ( The anti-inflammatory potential of GLP1-RAs (Glucagon-like peptide-1 receptor agonists) could depend on their direct effect on immune cells, an indirect effect caused by weight loss, or a combination of the two
Oral Wegovy Oral Wegovy (oral semaglutide for weight management) was approved in late 2025
CJC-1295 CJC-1295 is a long-acting growth hormone-releasing hormone analog that supports growth hormone and IGF-1 signaling
Laursen JC, Sondergaard-Heinrich N, Lopes de Melo JM et al (2021) Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: a randomised, double-blind, placebo-controlled crossover trial